Toxoplasma gondii vaccines and uses thereof
US8282942B2 · kind B2 · utility
1Cited by
0References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 6, 2010 |
| Grant date | Oct 9, 2012 |
| Priority date | — |
| Expiry date | Sep 26, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/523
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides attenuated Toxoplasma gondii knockout mutants of the de novo pyrimidine synthesis pathway and use of the same in vaccines and methods of providing an immune response and protecting a subject against infection by T. gondii and a non-T. gondii disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.